##analysisDate=2017-05-10-13-56-40000																																																			
##analyzedBy=RingStudy Site F																																																			
##exportDate=2017-11-08-10-47-16000																																																			
##analysisName=Site F-081-Sample 1_F																																																			
##workflowName=Oncomine Comprehensive v3 - w2.1 - DNA and Fusions - Single Sample																																																			
##sampleNames=Site F-081-Sample 1-F_v1:Site F-081-Sample 1-F_RNA_v1																																																			
##reference=hg19																																																			
##variantGroup=DEFAULT																																																			
##filterChain=Site D_NoRef																																																			
##searchText=																																																			
##chromosome=All																																																			
##totalVariantCount=2484																																																			
##filterInCount=107																																																			
##filteredOutCount=2377																																																			
##hiddenVariantCount=0																																																			
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:40363054	G/C	G	SNV		MYCL	exonic	1								39.85	p.Thr392Ser		1079	"G=0.6015, C=0.3985"		Present				-	3	NM_001033082.2	c.1175C>G	missense	1.32	1	58	0	"Helix-loop-helix DNA-binding domain,Myc amino-terminal region"	rs3134614		0.055 (ref)	0.1328	0.0252	0.0963	YES	"DNA binding,nucleus,regulation of transcription, DNA-dependent,sequence-specific DNA binding transcription factor activity"			0.00001	3518.77	"G=649, C=430"		"G=344/305, C=216/214"	1	
chr1:65310489	C/C	T	SNV		JAK1	exonic	1								100	p.(=)		1161	"T=0.0, C=1.0"		Present				-	16	NM_002227.2	c.2199A>G	synonymous	-4.13				"Protein kinase domain,Protein tyrosine kinase"	rs2230588		0.352 (ref)	0.2323	0.418	0.3492	YES	"ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway"	"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile"		0.00001	17489.1	"T=0, C=1161"		"T=0/0, C=528/633"	1	
chr1:65312342	G/A	G	SNV		JAK1	exonic	1								41.89	p.(=)		1172	"G=0.5811, A=0.4189"		Present				-	14	NM_002227.2	c.1977C>T	synonymous	-2				"Protein kinase domain,Protein tyrosine kinase"	rs17127063		0.053 (ref)	0.027	0.1076	0.054	YES	"ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway"	"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile"		0.00001	4115.28	"G=681, A=491"		"G=369/312, A=238/253"	1	
chr1:204485637		G	GENE_EXPRESSION		MDM4								MDM4.E1E2				81				Present			8.17E-11																						0					
chr1:204494724		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M2M11				75216				Present			7.58E-08																						0					
chr1:204494724		G	GENE_EXPRESSION		MDM4								MDM4.E3E4				6015				Present			6.06E-09																						0					
chr1:204507436		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M7M10				45				Present			4.54E-11																						0					
chr2:48023115	T/C	T	SNV		MSH6	exonic	1								48.65	p.(=)		2000	"T=0.5135, C=0.4865"		Present				+	3	NM_000179.2	c.540T>C	synonymous	0.06				"MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain"	rs1800935		0.174 (ref)	0.2866	0.1804	0.2507	YES	"ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments"		non-pathogenic	0.00001	8993.98	"T=1027, C=973"		"T=558/469, C=492/481"	1	
chr2:48025764	C/T	C	SNV		MSH6	exonic	1								43.67	p.(=)		1997	"C=0.5633, T=0.4367"		Present				+	4	NM_000179.2	c.642C>T	synonymous	-1.53				"MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain"	rs1800937		0.05	0.0931	0.0222	0.0691	YES	"ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments"		non-pathogenic	0.00001	7541.06	"C=1125, T=872"		"C=555/570, T=292/580"	1	
chr2:209113192	G/A	G	SNV		IDH1	exonic	1								49.37	p.(=)		1999	"G=0.5063, A=0.4937"		Present				-	4	NM_005896.3	c.315C>T	synonymous	1.35				Isocitrate/isopropylmalate dehydrogenase	rs11554137		0.049 (ref)	0.0531	0.106	0.071	YES	"2-oxoglutarate metabolic process,NAD binding,NADPH regeneration,carbohydrate metabolic process,cellular lipid metabolic process,cytoplasm,cytosol,glutathione metabolic process,glyoxylate cycle,isocitrate dehydrogenase (NADP+) activity,isocitrate metabolic process,magnesium ion binding,mitochondrion,oxidoreductase activity,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,peroxisomal matrix,peroxisome,protein homodimerization activity,response to oxidative stress,tricarboxylic acid cycle"	"2'-Monophosphoadenosine 5'-Diphosphoribose,Isocitric Acid"		0.00001	9203.38	"G=1012, A=987"		"G=525/487, A=487/500"	1	
chr2:212248603	G/T	G	SNV		ERBB4	exonic	1								14.49	p.Leu1222Met		1995	"G=0.8551, T=0.1449"		Present				-	28	NM_005235.2	c.3664C>A	missense	1.51	0.09	15	0.004	"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"								"ATP binding,apoptotic process,basolateral plasma membrane,cardiac muscle tissue regeneration,caveola,cell fate commitment,cell migration,cell proliferation,central nervous system morphogenesis,cytoplasm,embryonic pattern specification,epidermal growth factor receptor binding,heart development,integral to membrane,lactation,mammary gland alveolus development,mammary gland epithelial cell differentiation,mitochondrion,negative regulation of apoptotic process,negative regulation of cell proliferation,nervous system development,neural crest cell migration,nucleolus,nucleotide binding,nucleus,olfactory bulb interneuron differentiation,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of STAT protein import into nucleus,positive regulation of anti-apoptosis,positive regulation of cardiac muscle cell proliferation,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,positive regulation of glucose import,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of protein phosphorylation,positive regulation of synaptic transmission, GABAergic,positive regulation of transcription, DNA-dependent,positive regulation of tyrosine phosphorylation of Stat5 protein,postsynaptic density,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell migration,response to drug,response to hydrogen peroxide,response to progesterone stimulus,signal transduction,surfactant homeostasis,synapse maturation,telencephalon development,transcription regulatory region DNA binding,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			0.00001	1070.49	"G=1706, T=289"		"G=873/833, T=142/147"	2	
chr3:10106532	C/T	C	SNV		FANCD2	exonic	1								50.5	p.Pro714Leu		1998	"C=0.495, T=0.505"		Present				+	23	NM_033084.3	c.2141C>T	missense	-0.51	0.3	98	0.001		rs3864017		0.147 (ref)				YES	"DNA repair,cell cycle,condensed chromosome,gamete generation,nucleoplasm,nucleus,protein binding,response to gamma radiation,synapsis"			0.00001	9541.05	"C=989, T=1009"		"C=421/568, T=431/578"	2	
chr3:10138069	T/G	T	SNV		"FANCD2,FANCD2OS"	"exonic, intronic"	1								51.63	p.(=)		1999	"T=0.4837, G=0.5163"		Present				"+, -"	42	"NM_033084.3, NM_173472.1"	c.4098T>G	synonymous	0.37					rs2272125		0.228 (ref)	0.1647	0.4714	0.2686	YES	"DNA repair,cell cycle,condensed chromosome,gamete generation,nucleoplasm,nucleus,protein binding,response to gamma radiation,synapsis"			0.00001	9891.23	"T=967, G=1032"		"T=507/460, G=560/472"	4	
chr3:37053568	A/G	A	SNV		MLH1	exonic	1								50.98	p.Ile219Val		1999	"A=0.4902, G=0.5098"		Present				+	8	NM_000249.3	c.655A>G	missense	2.21	0.17	29	0.018	"DNA mismatch repair protein,Histidine kinase-"	rs1799977		0.172	0.3202	0.0921	0.243	YES	"ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,MutLalpha complex,MutLbeta complex,MutSalpha complex binding,cell cycle,cellular response to organic cyclic compound,chiasma,double-strand break repair via nonhomologous end joining,guanine/thymine mispair binding,isotype switching,male germ cell nucleus,male meiosis chromosome segregation,meiotic metaphase I plate congression,mismatch repair,mismatched DNA binding,negative regulation of mitotic recombination,nuclear-transcribed mRNA poly(A) tail shortening,nucleus,oogenesis,pachytene,protein binding,reciprocal meiotic recombination,resolution of meiotic recombination intermediates,response to drug,response to hypoxia,response to toxin,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,spermatogenesis,spindle midzone assembly involved in meiosis,synaptonemal complex"		"non-pathogenic,probable-non-pathogenic"	0.00001	9689.3	"A=980, G=1019"		"A=500/480, G=541/478"	1	
chr3:142222284	A/G	A	SNV		ATR	exonic	1								52.88	p.(=)		1999	"A=0.4712, G=0.5288"		Present				-	30	NM_001184.3	c.5208T>C	synonymous	0.03				"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2227931		0.352 (ref)	0.4189	0.2145	0.3496	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			0.00001	10266.4	"A=942, G=1057"		"A=435/507, G=540/517"	1	
chr3:142277536	A/G	A	SNV		ATR	exonic	1								47.67	p.(=)		1999	"A=0.5233, G=0.4767"		Present				-	8	NM_001184.3	c.1815T>C	synonymous	0.12				"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2227929		0.349 (ref)	0.414	0.2127	0.3458	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			0.00001	8698.25	"A=1046, G=953"		"A=561/485, G=507/446"	1	
chr3:142277575	A/T	A	SNV		ATR	exonic	1								50.18	p.(=)		1999	"A=0.4982, T=0.5018"		Present				-	8	NM_001184.3	c.1776T>A	synonymous	-0.09				"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2227930		0.382 (ref)	0.405	0.2043	0.337	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			0.00001	9447.95	"A=996, T=1003"		"A=542/454, T=565/438"	1	
chr3:142281612	A/G	A	SNV		ATR	exonic	1								53.19	p.Met211Thr		1993	"A=0.4681, G=0.5319"		Present				-	4	NM_001184.3	c.632T>C	missense	0.55	1	81	0	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain"	rs2227928		0.383 (ref)	0.4045	0.2072	0.3377	YES	"ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus"			0.00001	10346.9	"A=933, G=1060"		"A=450/483, G=503/557"	1	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100	p.(=)		462	"G=0.0, A=1.0"		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs7688609		0.042 (ref)	8.00E-04	0.131	0.0449	YES	"ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development"	"Palifermin,Pazopanib"		0.00001	6982.68	"G=0, A=462"		"G=0/0, A=198/264"	1	
chr4:55141051	GCCCGGATGGACATGA/GCCCGGATGGACATGA	GCCCAGATGGACATGA	SNV		PDGFRA	exonic	1					HS	COSM12418		"G=0.00, GCCCGGATGGACATGA=100.00"	p.(=)		1963	"GCCCAGATGGACATGA=0.0, G=0.0, GCCCGGATGGACATGA=1.0"		Present				+	12	NM_006206.4	c.1701A>G	synonymous	"2.79,2.74,2.74,2.74,-5.31,2.74,2.21,0.99,2.74,2.74,0.41,2.64,2.31,-0.28,1.57,2.31"				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	"rs121913270,rs121913271,rs1873778,rs201503614"		0.037				YES	"ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing"	"Becaplermin,Imatinib,Pazopanib,Sunitinib"		0.00001	28528.6	"GCCCAGATGGACATGA=0, G=0, GCCCGGATGGACATGA=1963"		"GCCCAGATGGACATGA=0/0, G=0/0, GCCCGGATGGACATGA=937/1026"	"3,1"	
chr4:55593481	A/G	A	SNV		KIT	exonic	1								50.98	p.(=)		1999	"A=0.4902, G=0.5098"		Present				+	10	NM_000222.2	c.1638A>G	synonymous	0.19				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs55986963		0.022 (ref)	0.0305	0.0052	0.0219	YES	"ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"	"Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib"		0.00001	9685.65	"A=980, G=1019"		"A=535/445, G=559/460"	3	
chr5:1294166	C/T	C	SNV		TERT	exonic	1								48.06	p.Ala279Thr		645	"C=0.5194, T=0.4806"		Present				-	2	NM_198253.2	c.835G>A	missense	0.24	0.52	58	0.98		rs61748181		0.014 (ref)	0.0297	0.0046	0.0212	YES	"DNA binding,DNA strand elongation,PML body,anti-apoptosis,chromosome,chromosome, telomeric region,cytoplasm,metal ion binding,nuclear telomere cap complex,nucleolus,nucleoplasm,nucleotidyltransferase activity,nucleus,protein binding,protein homodimerization activity,replicative senescence,telomerase activity,telomerase holoenzyme complex,telomere formation via telomerase,telomere maintenance,telomere maintenance via telomerase,telomeric DNA binding,telomeric RNA binding,telomeric template RNA reverse transcriptase activity,transferase activity"		pathogenic	0.00001	2816.05	"C=335, T=310"		"C=160/175, T=140/170"	1	
chr5:176516631	G/A	G	SNV		FGFR4	exonic	1								51.46	p.Val10Ile		993	"G=0.4854, A=0.5146"		Present				+	2	NM_213647.1	c.28G>A	missense	-0.41	0.35	29	0	"Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs1966265		0.249 (ref)	0.227	0.0611	0.1708	YES	"ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process"	Palifermin		0.00001	4889.29	"G=482, A=511"		"G=253/229, A=228/283"	5	
chr6:41903782	C/C	A	SNV		CCND3	exonic	1								100	p.Ser259Ala		1211	"A=0.0, C=1.0"		Present				-	5	NM_001760.4	c.775T>G	missense	-0.25	0.59	99	0	Cyclin	rs1051130		0.415 (ref)	0.4535	0.2238	0.3757	YES	"T cell proliferation,cell division,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,membrane,nucleus,positive regulation of cyclin-dependent protein kinase activity,positive regulation of protein phosphorylation,protein binding,protein kinase binding,regulation of cell cycle,signal transduction"			0.00001	18290.7	"A=0, C=1211"		"A=0/0, C=537/674"	1	
chr6:117622184	G/C	G	SNV		ROS1	exonic	1								51.61	p.Ser2229Cys		1209	"G=0.4839, C=0.5161"		Present				-	42	NM_002944.2	c.6686C>G	missense	0.09	1	112	0	"Fibronectin type III domain,Protein kinase domain,Protein tyrosine kinase"	rs619203		0.16 (ref)	0.2598	0.0742	0.1969	YES	"ATP binding,cell differentiation,cell growth,cell proliferation,columnar/cuboidal epithelial cell development,integral to membrane,membrane fraction,negative regulation of gene expression,nucleotide binding,plasma membrane,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of TOR signaling cascade,regulation of phosphate transport,spermatogenesis,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			0.00001	5967.36	"G=585, C=624"		"G=291/294, C=301/323"	2	
chr6:117622188	T/G	T	SNV		ROS1	exonic	1								51.53	p.Lys2228Gln		1213	"T=0.4847, G=0.5153"		Present				-	42	NM_002944.2	c.6682A>C	missense	1.45	0.36	53	0	"Fibronectin type III domain,Protein kinase domain,Protein tyrosine kinase"	rs529156		0.16 (ref)	0.2598	0.0742	0.1969	YES	"ATP binding,cell differentiation,cell growth,cell proliferation,columnar/cuboidal epithelial cell development,integral to membrane,membrane fraction,negative regulation of gene expression,nucleotide binding,plasma membrane,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of TOR signaling cascade,regulation of phosphate transport,spermatogenesis,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			0.00001	5970.58	"T=588, G=625"		"T=293/295, G=300/325"	2	
chr6:117622233	C/T	C	SNV		ROS1	exonic	1								51.34	p.Asp2213Asn		1196	"C=0.4866, T=0.5134"		Present				-	42	NM_002944.2	c.6637G>A	missense	0.75	0.22	23	0.009	"Fibronectin type III domain,Protein kinase domain,Protein tyrosine kinase"	rs529038		0.158	0.2594	0.0688	0.1948	YES	"ATP binding,cell differentiation,cell growth,cell proliferation,columnar/cuboidal epithelial cell development,integral to membrane,membrane fraction,negative regulation of gene expression,nucleotide binding,plasma membrane,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of TOR signaling cascade,regulation of phosphate transport,spermatogenesis,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			0.00001	5833.27	"C=582, T=614"		"C=285/297, T=286/328"	2	
chr6:152129077	C/C	T	SNV		ESR1	exonic	1								100	p.(=)		474	"T=0.0, C=1.0"		Present				+	2	NM_001122740.1	c.30T>C	synonymous	-1.28				"Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger"	rs2077647		0.432 (ref)	0.4769	0.4828	0.4789	YES	"Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding"	"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate"		0.00001	7210.23	"T=0, C=474"		"T=0/0, C=272/202"	1	
chr6:152201875	C/C	T	SNV		ESR1	exonic	1								100	p.(=)		1999	"T=0.0, C=1.0"		Present				+	4	NM_001122740.1	c.729T>C	synonymous	0.22				"Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger"	rs4986934		0.018 (ref)	0.04	0.0082	0.0292	YES	"Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding"	"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate"		0.00001	30459.9	"T=0, C=1999"		"T=0/0, C=890/1109"	1	
chr6:152265522	C/C	G	SNV		ESR1	exonic	1								100	p.(=)		1993	"G=0.0, C=1.0"		Present				+	5	NM_001122740.1	c.975G>C	synonymous	-0.42				"Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger"	rs1801132		0.262 (ref)	0.2257	0.1074	0.1856	YES	"Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding"	"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate"		0.00001	29798.3	"G=0, C=1993"		"G=0/0, C=1009/984"	1	
chr7:6026775	C/C	T	SNV		PMS2	exonic	1								100	p.Lys541Glu		1982	"T=0.0, C=1.0"		Present				-	11	NM_000535.5	c.1621A>G	missense	0.74	1	56	0	"DNA mismatch repair protein,Histidine kinase-"	rs2228006		0.121 (ref)	0.1543	0.0815	0.1296	YES	"ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments"	"Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester"		0.00001	29854.6	"T=0, C=1982"		"T=0/0, C=893/1089"	4	
chr7:6026988	A/A	G	SNV		PMS2	exonic	1								100	p.Pro470Ser		1992	"G=0.0, A=1.0"		Present				-	11	NM_000535.5	c.1408C>T	missense	0.39	0.51	74	0.002	"DNA mismatch repair protein,Histidine kinase-"	rs1805321		0.394 (ref)	0.4209	0.2819	0.3738	YES	"ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments"	"Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester"	non-pathogenic	0.00001	30196.4	"G=0, A=1992"		"G=0/0, A=1021/971"	2	
chr7:6036980	C/C	G	SNV		PMS2	exonic	1								100	p.(=)		1991	"G=0.0, C=1.0"		Present				-	7	NM_000535.5	c.780C>G	synonymous	-5.63				"DNA mismatch repair protein,Histidine kinase-"	rs1805319		0.157 (ref)	0.1852	0.1586	0.1762	YES	"ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments"	"Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester"	non-pathogenic	0.00001	30246.2	"G=0, C=1991"		"G=0/0, C=1123/868"	2	
chr7:55220357		G	GENE_EXPRESSION		EGFR								EGFR.E6E7				996				Present			1.00E-09																						0					
chr7:55249063	G/A	G	SNV		"EGFR,EGFR-AS1"	"exonic, exonic_nc"	1								53.48	p.(=)		933	"G=0.4652, A=0.5348"		Present				"+, -"	20	"NM_005228.3, NR_047551.1"	c.2361G>A	synonymous	2.8				"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs1050171		0.418 (ref)	0.3962	0.4226	0.4576	YES	"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"		0.00001	4839.39	"G=434, A=499"		"G=228/206, A=239/260"	1	
chr7:55266417	T/C	T	SNV		EGFR	exonic	1								48.52	p.(=)		1997	"T=0.5148, C=0.4852"		Present				+	23	NM_005228.3	c.2709T>C	synonymous	-1.92				"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs1140475		0.095 (ref)	0.1267	0.0801	0.1109	YES	"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"		0.00001	8942.41	"T=1028, C=969"		"T=589/439, C=516/453"	1	
chr7:55269475		G	GENE_EXPRESSION		EGFR								EGFR.E26E27				243				Present			2.45E-10																						0					
chr7:92355033	T/A	T	SNV		CDK6	exonic	1								44.28	p.(=)		1897	"T=0.5572, A=0.4428"		Present				-	4	NM_001145306.1	c.444A>T	synonymous	-0.44				"Protein kinase domain,Protein tyrosine kinase"	rs34257565		0.011 (ref)	0.0123	0.0025	0.009		"ATP binding,G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,astrocyte development,cell cycle,cell cycle arrest,cell dedifferentiation,cell division,cyclin binding,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,cytosol,dentate gyrus development,generation of neurons,gliogenesis,hemopoiesis,lateral ventricle development,mitotic cell cycle,negative regulation of cell cycle,negative regulation of cell differentiation,negative regulation of cell proliferation,negative regulation of cellular senescence,negative regulation of epithelial cell proliferation,negative regulation of myeloid cell differentiation,negative regulation of osteoblast differentiation,nucleotide binding,nucleus,positive regulation of cell-matrix adhesion,positive regulation of fibroblast proliferation,protein binding,protein phosphorylation,regulation of cell motility,regulation of erythrocyte differentiation,regulation of gene expression,response to virus,ruffle,type B pancreatic cell development"	"(2S)-2-({6-(3-AMINO-5-CHLOROPHENYL)AMINO-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL,3,7,3',4'-TETRAHYDROXYFLAVONE,Flavopiridol"		0.00001	7301.24	"T=1057, A=840"		"T=472/585, A=372/468"	1	
chr7:140439646		T	GENE_EXPRESSION		BRAF								BRAF.E16E17				35468				Present			3.58E-08																						0					
chr8:38285936	C/T	C	SNV		FGFR1	exonic	1								3.77	p.Glu159Lys		1301	"C=0.9623, T=0.0377"		Present				-	5	NM_001174067.1	c.475G>A	missense	2.69	0	56	0.998	"Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"								"ATP binding,MAPKKK cascade,axon guidance,cell migration,chordate embryonic development,cytoplasm,cytoplasmic membrane-bounded vesicle,cytosol,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,heparin binding,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,neuron migration,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of neuron differentiation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of phospholipase activity,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell differentiation,regulation of transcription, DNA-dependent,skeletal system development,skeletal system morphogenesis"	"(E)-4-(3,5-difluorophenyl)-3H-pyrrolo2,3-bpyridin-3-ylidene(3-methoxyphenyl)methanol,3-(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE-2-INDOLINONE,3-(3-methoxybenzyl)-1H-pyrrolo2,3-bpyridine,Palifermin,SU4984"		0.0383	14.1682	"C=1252, T=49"		"C=608/644, T=17/32"	2	
chr8:90958422	T/C	T	SNV		NBN	exonic	1								49.3	p.(=)		2000	"T=0.507, C=0.493"		Present				-	13	NM_002485.4	c.2016A>G	synonymous	-1.06				"BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain"	rs1061302		0.328 (ref)	0.3132	0.2276	0.2842	YES	"ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding"			0.00001	9188.5	"T=1014, C=986"		"T=505/509, C=499/487"	1	
chr8:90967711	A/G	A	SNV		NBN	exonic	1								51.03	p.(=)		1999	"A=0.4897, G=0.5103"		Present				-	10	NM_002485.4	c.1197T>C	synonymous	-0.48				"BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain"	rs709816		0.424 (ref)	0.3559	0.2473	0.4903	YES	"ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding"			0.00001	9706.77	"A=979, G=1020"		"A=531/448, G=581/439"	1	
chr8:90990479	C/G	C	SNV		NBN	exonic	1								50.48	p.Glu185Gln		1153	"C=0.4952, G=0.5048"		Present				-	5	NM_002485.4	c.553G>C	missense	0.09	1	29	0	"BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain"	rs1805794		0.333 (ref)	0.3136	0.2338	0.2866	YES	"ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding"			0.00001	5499.58	"C=571, G=582"		"C=284/287, G=306/276"	1	
chr8:90995019	C/T	C	SNV		NBN	exonic	1								47.8	p.(=)		2000	"C=0.522, T=0.478"		Present				-	2	NM_002485.4	c.102G>A	synonymous	-0.39				"BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain"	rs1063045		0.35 (ref)	0.3147	0.3103	0.3132	YES	"ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding"			0.00001	8736.87	"C=1044, T=956"		"C=508/536, T=454/502"	1	
chr9:22006119	G/A	G	SNV		"CDKN2B,CDKN2B-AS1"	"intronic_nc, exonic"	1								11.11	p.Thr95Met		27	"G=0.8889, A=0.1111"		Present				"+, -"	2	"NR_047543.1, NM_004936.3"	c.284C>T	missense	2.47	0.01	81	1									"G1 phase of mitotic cell cycle,G2/M transition of mitotic cell cycle,cell cycle arrest,cellular response to extracellular stimulus,cellular response to nutrient,cyclin-dependent protein kinase inhibitor activity,cytoplasm,cytosol,megakaryocyte differentiation,mitotic cell cycle,mitotic cell cycle G1/S transition checkpoint,negative regulation of cell proliferation,negative regulation of epithelial cell proliferation,negative regulation of phosphorylation,nucleus,positive regulation of epithelial cell differentiation,positive regulation of transforming growth factor beta receptor signaling pathway,protein binding,protein kinase binding,regulation of cyclin-dependent protein kinase activity,response to cytokine stimulus,response to organic cyclic compound"			0.01121	19.5041	"G=24, A=3"		"G=15/9, A=2/1"	1	
chr9:98209594	G/A	G	SNV		PTCH1	exonic	1								47.17	p.Pro1315Leu		494	"G=0.5283, A=0.4717"		Present				-	23	NM_000264.3	c.3944C>T	missense	2.51	0	98	0.906	Patched family	rs357564		0.382 (ref)	0.3298	0.2389	0.2993	YES	"Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development"			0.00001	2094.32	"G=261, A=233"		"G=119/142, A=113/120"	6	
chr9:139391636	A/A	G	SNV		NOTCH1	exonic	1								100	p.(=)		479	"G=0.0, A=1.0"		Present				-	34	NM_017617.3	c.6555C>T	synonymous	-0.09				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs2229974		0.305 (ref)	0.4467	0.3639	0.4187	YES	"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			0.00001	7181.21	"G=0, A=479"		"G=0/0, A=283/196"	1	
chr9:139397707	A/A	G	SNV		NOTCH1	exonic	1								100	p.(=)		587	"G=0.0, A=1.0"		Present				-	27	NM_017617.3	c.5094C>T	synonymous	-0.82				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs10521		0.417 (ref)	0.3534	0.4829	0.408	YES	"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			0.00001	8898.47	"G=0, A=587"		"G=0/0, A=346/241"	1	
chr9:139407932	A/G	A	SNV		NOTCH1	exonic	1								50.1	p.(=)		1994	"A=0.499, G=0.501"		Present				-	14	NM_017617.3	c.2265T>C	synonymous	-1.25				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs2229971		0.444 (ref)	0.2858	0.3844	0.3975	YES	"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			0.00001	9389.91	"A=995, G=999"		"A=484/511, G=495/504"	1	
chr9:139418260	A/G	A	SNV		NOTCH1	exonic	1								54	p.(=)		513	"A=0.46, G=0.54"		Present				-	3	NM_017617.3	c.312T>C	synonymous	-1.16				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein"	rs4489420		0.293 (ref)	0.4711	0.1191	0.3913	YES	"Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration"			0.00001	2735.79	"A=236, G=277"		"A=126/110, G=164/113"	1	
chr10:43613843	T/T	G	SNV		RET	exonic	1								100	p.(=)		357	"G=0.0, T=1.0"		Present				+	13	NM_020975.4	c.2307G>T	synonymous	1.34				"Cadherin domain,Protein kinase domain,Protein tyrosine kinase"	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	"ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development"	"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib"	untested	0.00001	5285.73	"G=0, T=357"		"G=0/0, T=169/188"	1	
chr10:123298158	C/C	T	SNV		FGFR2	exonic	1								100	p.(=)		1995	"T=0.0, C=1.0"		Present				-	6	NM_000141.4	c.696A>G	synonymous	0.96				"Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs1047100		0.176 (ref)	0.2236	0.2522	0.2333	YES	"ATP binding,Golgi apparatus,angiogenesis,apoptotic process,axonogenesis,bone development,bone mineralization,bone morphogenesis,branch elongation involved in salivary gland morphogenesis,branching involved in embryonic placenta morphogenesis,branching involved in prostate gland morphogenesis,branching involved in salivary gland morphogenesis,branching morphogenesis of a nerve,bud elongation involved in lung branching,cell cortex,cell fate commitment,cell surface,cell-cell signaling,cytoplasm,cytoplasmic membrane-bounded vesicle,digestive tract development,embryonic digestive tract morphogenesis,embryonic organ development,embryonic organ morphogenesis,embryonic pattern specification,epidermis morphogenesis,epithelial cell differentiation,epithelial cell proliferation involved in salivary gland morphogenesis,excitatory synapse,extracellular matrix,extracellular region,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,fibroblast growth factor-activated receptor activity,gland morphogenesis,hair follicle morphogenesis,heparin binding,in utero embryonic development,inner ear morphogenesis,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,lacrimal gland development,lateral sprouting from an epithelium,limb bud formation,lung alveolus development,lung development,lung lobe morphogenesis,lung-associated mesenchyme development,mammary gland bud formation,membrane,membranous septum morphogenesis,mesenchymal cell differentiation,mesenchymal cell differentiation involved in lung development,mesenchymal cell proliferation involved in lung development,midbrain development,morphogenesis of embryonic epithelium,multicellular organism growth,negative regulation of transcription from RNA polymerase II promoter,nucleotide binding,nucleus,odontogenesis,orbitofrontal cortex development,organ growth,organ morphogenesis,otic vesicle formation,outflow tract septum morphogenesis,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Wnt receptor signaling pathway,positive regulation of canonical Wnt receptor signaling pathway,positive regulation of cardiac muscle cell proliferation,positive regulation of cell cycle,positive regulation of cell division,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,positive regulation of epithelial cell proliferation involved in lung morphogenesis,positive regulation of mesenchymal cell proliferation,positive regulation of phospholipase activity,positive regulation of transcription from RNA polymerase II promoter,post-embryonic development,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,prostate gland morphogenesis,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,pyramidal neuron development,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of branching involved in prostate gland morphogenesis,regulation of cell fate commitment,regulation of fibroblast growth factor receptor signaling pathway,regulation of morphogenesis of a branching structure,regulation of multicellular organism growth,regulation of osteoblast differentiation,regulation of osteoblast proliferation,regulation of smooth muscle cell differentiation,regulation of smoothened signaling pathway,reproductive structure development,skeletal system morphogenesis,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,ureteric bud development,ventricular cardiac muscle tissue morphogenesis,ventricular zone neuroblast division"	"4-4-(1-Amino-1-Methylethyl)Phenyl-5-Chloro-N-4-(2-Morpholin-4-Ylethyl)PhenylPyrimidin-2-Amine,Palifermin,SU4984,Thalidomide"		0.00001	30356.7	"T=0, C=1995"		"T=0/0, C=1005/990"	1	
chr11:534242	A/G	A	SNV		HRAS	exonic	1								50.96	p.(=)		624	"A=0.4904, G=0.5096"		Present				-	2	NM_001130442.1	c.81T>C	synonymous	0				"Miro-like protein,Ras family"	rs12628		0.297 (ref)	0.3441	0.3749	0.3545	YES	"GTP binding,GTPase activity,Golgi apparatus,Golgi membrane,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,actin cytoskeleton organization,activation of MAPKK activity,apoptotic process,axon guidance,blood coagulation,cell cycle arrest,cell surface receptor linked signaling pathway,cellular senescence,chemotaxis,cytoplasm,cytosol,endocytosis,epidermal growth factor receptor signaling pathway,induction of apoptosis by intracellular signals,insulin receptor signaling pathway,leukocyte migration,membrane fraction,microsome,mitotic cell cycle G1/S transition checkpoint,negative regulation of cell proliferation,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Rac protein signal transduction,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,protein C-terminus binding,protein binding,regulation of long-term neuronal synaptic plasticity,regulation of synaptic transmission, GABAergic,signal transduction,small GTPase mediated signal transduction,social behavior,soluble fraction,striated muscle cell differentiation,synaptic transmission,visual learning"	"Guanosine-5'-Diphosphate,Guanosine-5'-Triphosphate,Hexane-1,6-Diol,N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE,Trifluoroethanol"		0.00001	3012.23	"A=306, G=318"		"A=148/158, G=167/151"	4	
chr11:108175462	G/A	G	SNV		ATM	exonic	1	Hotspot	Loss-of-function						48.8	p.Asp1853Asn		1998	"G=0.512, A=0.488"		Present				+	37	NM_000051.3	c.5557G>A	missense	2.75	0.07	23	0.044	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"	rs1801516		0.079 (ref)	0.1402	0.0284	0.1023	YES	"1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle"			0.00001	8957.94	"G=1023, A=975"		"G=520/503, A=495/480"	1	
chr11:108183167	G/G	A	SNV		ATM	exonic	1								100	p.Asn1983Ser		1989	"A=0.0, G=1.0"		Present				+	40	NM_000051.3	c.5948A>G	missense	-0.19	1	46	0	"FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase"	rs659243		0.0 (ref)					"1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle"			0.00001	30084.9	"A=0, G=1989"		"A=0/0, G=1165/824"	2	
chr11:125525195	G/G	A	SNV		CHEK1	exonic	1								100	p.Ile471Val		1991	"A=0.0, G=1.0"		Present				+	13	NM_001274.5	c.1411A>G	missense	0.45	1	29	0	"Protein kinase domain,Protein tyrosine kinase"	rs506504		0.017 (ref)	0.0363	0.0064	0.0262	YES	"ATP binding,DNA damage checkpoint,DNA damage induced protein phosphorylation,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,G2/M transition of mitotic cell cycle,cell cycle,cell cycle checkpoint,cellular response to caffeine,cellular response to mechanical stimulus,cellular response to organic substance,centrosome,chromatin,chromatin-mediated maintenance of transcription,chromosome, telomeric region,condensed nuclear chromosome,cytoplasm,cytoskeleton,histone H3-T11 phosphorylation,histone kinase activity (H3-T11 specific),negative regulation of mitosis,nucleoplasm,nucleotide binding,nucleus,peptidyl-threonine phosphorylation,protein binding,protein serine/threonine kinase activity,regulation of S phase,regulation of double-strand break repair via homologous recombination,regulation of histone H3-K9 acetylation,regulation of mitotic centrosome separation,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,replication fork,replicative senescence,response to DNA damage stimulus"	"(2R)-1-(5,6-DIPHENYL-7H-PYRROLO2,3-DPYRIMIDIN-4-YL)AMINOPROPAN-2-OL,(2R)-3-{(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO2,3-DPYRIMIDIN-4-YLIDENEAMINO}PROPANE-1,2-DIOL,(2S)-1-AMINO-3-(5-NITROQUINOLIN-8-YL)AMINOPROPAN-2-OL,(3-ENDO)-8-METHYL-8-AZABICYCLO3.2.1OCT-3-YL 1H-PYRROLO2,3-BPYRIDINE-3-CARBOXYLATE,(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE,(5,6-DIPHENYL-FURO2,3-DPYRIMIDIN-4-YLAMINO)-ACETIC,(5-{3-5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL,1-(2S)-4-(5-BROMO-1H-PYRAZOLO3,4-BPYRIDIN-4-YL)MORPHOLIN-2-YLMETHANAMINE,1-(2S)-4-(5-phenyl-1H-pyrazolo3,4-bpyridin-4-yl)morpholin-2-ylmethanamine,1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-2-(DIMETHYLAMINO)-1-METHYLETHOXYPYRAZIN-2-YL}UREA,18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE,2,2'-{9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYLBIS(OXY)}DIACETIC ACID,2-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)AMINOETHANOL,2-(cyclohexylamino)benzoic acid,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,2-5,6-BIS-(4-METHOXY-PHENYL)-FURO2,3-DPYRIMIDIN-4-YLAMINO-ETHANOL,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,3-AMINO-3-BENZYL-4.3.0BICYCLO-1,6-DIAZANONAN-2-ONE,4-(3S)-1-AZABICYCLO2.2.2OCT-3-YLAMINO-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,4-(6-{(4-METHYLCYCLOHEXYL)AMINOMETHYL}-1,4-DIHYDROINDENO1,2-CPYRAZOL-3-YL)BENZOIC ACID,4-3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL-2-METHOXYPHENOL,4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl(phenyl)methanone,5,6,7,8-TETRAHYDRO1BENZOTHIENO2,3-DPYRIMIDIN-4(3H)-ONE,5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO4,3-CQUINOLIN-4-ONE,6-MORPHOLIN-4-YL-9H-PURINE,N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-1,3THIAZOLO5,4-CAZEPIN-2-YL)ACETAMIDE,N-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)GLYCINE,N-{5-4-(4-METHYLPIPERAZIN-1-YL)PHENYL-1H-PYRROLO2,3-BPYRIDIN-3-YL}NICOTINAMIDE,REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO1,2,3-FG:3',2',1'-KLPYRROLO3,4-I1,6BENZODIAZOCINE-1,3(2H)-DIONE"		0.00001	30208.5	"A=0, G=1991"		"A=0/0, G=888/1103"	1	
chr12:25368462	T/T	C	SNV		KRAS	exonic	1								100	p.(=)		1987	"C=0.0, T=1.0"		Present				-	5	NM_033360.3	c.483G>A	synonymous	1.06				"Miro-like protein,Ras family"	rs4362222		0.0 (ref)	0	0.0043	0.0015		"GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior"	"(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE"		0.00001	30047.6	"C=0, T=1987"		"C=0/0, T=965/1022"	3	
chr12:25398284	CC/AC	CC	SNV		KRAS	exonic	1	Hotspot	Gain-of-function			HS	COSM520;COSM522;COSM521;COSM512;COSM514;COSM34144;COSM25081;COSM13643		"AA=0.00, AC=14.94, AG=0.00, AT=0.00, GC=0.00, TA=0.00, TC=0.00, TT=0.00"	p.Gly12Val		1995	"CC=0.8506, AA=0.0, AC=0.1494, AG=0.0, AT=0.0, GC=0.0, TA=0.0, TC=0.0, TT=0.0"		Present				-	2	NM_033360.3	c.35G>T	missense	"2.67,2.67"	0.01	109	0.999	"Miro-like protein,Ras family"	"rs121913529,rs121913530"							"GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior"	"(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE"	other	0.00001	975.22	"CC=1697, AA=0, AC=298, AG=0, AT=0, GC=0, TA=0, TC=0, TT=0"		"CC=871/826, AA=0/0, AC=143/155, AG=0/0, AT=0/0, GC=0/0, TA=0/0, TC=0/0, TT=0/0"	"2,2,2,2,2,2,2,2"	
chr12:133208979	T/C	T	SNV		POLE	exonic	1								48.94	p.(=)		1833	"T=0.5106, C=0.4894"		Present				-	45	NM_006231.3	c.6252A>G	synonymous	-2.14				"DNA polymerase family B,Domain of unknown function (DUF1744)"	rs5745022		0.307 (ref)	0.4157	0.2433	0.3573	YES	"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		0.00001	8317.69	"T=936, C=897"		"T=449/487, C=413/484"	1	
chr12:133212582	G/A	G	SNV		POLE	exonic	1								53.06	p.(=)		703	"G=0.4694, A=0.5306"		Present				-	42	NM_006231.3	c.5707C>T	synonymous	-0.23				"DNA polymerase family B,Domain of unknown function (DUF1744)"	rs5744990		0.135 (ref)	0.1601	0.1455	0.1552	YES	"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		0.00001	3620.05	"G=330, A=373"		"G=173/157, A=220/153"	1	
chr12:133253995	G/A	G	SNV		POLE	exonic	1								52.08	p.Ala252Val		1995	"G=0.4792, A=0.5208"		Present				-	8	NM_006231.3	c.755C>T	missense	2.65	0.64	64	0.007	"DNA polymerase family B,Domain of unknown function (DUF1744)"	rs5744751		0.072 (ref)	0.1073	0.0159	0.0763	YES	"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		0.00001	9822.62	"G=956, A=1039"		"G=466/490, A=516/523"	1	
chr12:133257789	G/A	G	SNV		POLE	exonic	1								41.7	p.Arg47Trp		1235	"G=0.583, A=0.417"		Present				-	2	NM_006231.3	c.139C>T	missense	2.4	0	101	0.995	"DNA polymerase family B,Domain of unknown function (DUF1744)"	rs143626223		0.0 (ref)	0.0012	7.00E-04	0.001		"DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding"	Cladribine		0.00001	4328.83	"G=720, A=515"		"G=371/349, A=227/288"	1	
chr13:28636084	A/A	G	SNV		FLT3	exonic	1								100	p.(=)		1997	"G=0.0, A=1.0"		Present				-	3	NM_004119.2	c.288C>T	synonymous	0.04				"Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs7338903		0.041 (ref)	0.0105	0.0978	0.0401	YES	"ATP binding,cell surface,cellular response to cytokine stimulus,cytokine receptor activity,cytokine-mediated signaling pathway,endoplasmic reticulum,endoplasmic reticulum lumen,hemopoiesis,integral to plasma membrane,lymphocyte differentiation,membrane,myeloid progenitor cell differentiation,negative regulation of B cell differentiation,negative regulation of cell proliferation,nucleotide binding,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of tyrosine phosphorylation of STAT protein,pro-B cell differentiation,pro-T cell differentiation,protein autophosphorylation,protein homodimerization activity,receptor activity,regulation of apoptotic process,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity"	"Sorafenib,Sunitinib"		0.00001	30451.5	"G=0, A=1997"		"G=0/0, A=1001/996"	1	
chr13:32899321		G	GENE_EXPRESSION		BRCA2								BRCA2.E5E6				3492				Present			3.52E-09																						0					
chr13:32912299	C/C	T	SNV		BRCA2	exonic	1								98.77	p.(=)		734	"T=0.0123, C=0.9877"		Present				+	11	NM_000059.3	c.3807T>C	synonymous	0.04				BRCA2 repeat	rs543304		0.179	0.1874	0.1984	0.1911	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		untested	0.00001	10788.5	"T=9, C=725"		"T=5/4, C=342/383"	2	
chr13:32913055	G/G	A	SNV		BRCA2	exonic	1								100	p.(=)		1997	"A=0.0, G=1.0"		Present				+	11	NM_000059.3	c.4563A>G	synonymous	0.6				BRCA2 repeat	rs206075		0.026 (ref)	6.00E-04	0.0704	0.0242	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"			0.00001	30373.5	"A=0, G=1997"		"A=0/0, G=1085/912"	1	
chr13:32915005	C/C	G	SNV		BRCA2	exonic	1								100	p.(=)		1996	"G=0.0, C=1.0"		Present				+	11	NM_000059.3	c.6513G>C	synonymous	-1.1				BRCA2 repeat	rs206076		0.026 (ref)	6.00E-04	0.0713	0.0245	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"			0.00001	30416.4	"G=0, C=1996"		"G=0/0, C=1133/863"	1	
chr13:32929387	C/C	T	SNV		BRCA2	exonic	1								100	p.Val2466Ala		1997	"T=0.0, C=1.0"		Present				+	14	NM_000059.3	c.7397T>C	missense	1.27	0.58	64	0	BRCA2 repeat	rs169547		0.022 (ref)	6.00E-04	0.0647	0.0223	YES	"BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis"		untested	0.00001	30397.5	"T=0, C=1997"		"T=0/0, C=989/1008"	1	
chr15:88576185	G/C	G	SNV		NTRK3	exonic	1								51.99	p.(=)		931	"G=0.4801, C=0.5199"		Present				-	14	NM_001012338.2	c.1488C>G	synonymous	-2.01				"Immunoglobulin I-set domain,Immunoglobulin domain,Leucine rich repeat N-terminal domain,Protein kinase domain,Protein tyrosine kinase"	rs2229910		0.322 (ref)	0.3551	0.4048	0.3719	YES	"ATP binding,Golgi membrane,cell differentiation,cellular response to retinoic acid,cochlea development,cytoplasm,integral to plasma membrane,mechanoreceptor differentiation,membrane fraction,modulation by virus of host transcription,multicellular organismal development,negative regulation of astrocyte differentiation,negative regulation of cell death,nervous system development,neuron fate specification,neuron migration,neurotrophin binding,nucleotide binding,plasma membrane,positive regulation of axon extension involved in regeneration,protein autophosphorylation,receptor activity,response to axon injury,response to corticosterone stimulus,response to ethanol,response to stress,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			0.00001	4585.81	"G=447, C=484"		"G=198/249, C=220/264"	2	
chr15:89804043	T/T	C	SNV		FANCI	exonic	1								100	p.Ala86Val		1996	"C=0.0, T=1.0"		Present				+	4	NM_001113378.1	c.257C>T	missense	2.53	0.2	64	0.191		rs17803620		0.285 (ref)	0.3843	0.0948	0.2863	YES	"DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding"			0.00001	30321.7	"C=0, T=1996"		"C=0/0, T=972/1024"	1	
chr15:89836228	C/C	G	SNV		FANCI	exonic	1								100	p.Cys742Ser		1634	"G=0.0, C=1.0"		Present				+	22	NM_001113378.1	c.2225G>C	missense	2.79	0.66	112	0.007		rs2283432		0.291 (ref)	0.3895	0.0953	0.2899	YES	"DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding"			0.00001	24816.7	"G=0, C=1634"		"G=0/0, C=919/715"	1	
chr15:89838236	A/A	G	SNV		FANCI	exonic	1								100	p.(=)		1997	"G=0.0, A=1.0"		Present				+	24	NM_001113378.1	c.2547G>A	synonymous	0.3					rs7183618		0.027 (ref)	0.0535	0.0087	0.0399	YES	"DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding"			0.00001	30346.5	"G=0, A=1997"		"G=0/0, A=1008/989"	2	
chr15:89838318	A/T	A	SNV		FANCI	exonic	1								50.09	p.Ile877Leu		1639	"A=0.4991, T=0.5009"		Present				+	24	NM_001113378.1	c.2629A>T	missense	2.29	0.15	5	0.072		rs35875311		0.064 (ref)	0.1097	0.021	0.0829	YES	"DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding"			0.00001	7685.01	"A=818, T=821"		"A=440/378, T=434/387"	1	
chr16:3639139	G/G	A	SNV		SLX4	exonic	1								100	p.(=)		555	"A=0.0, G=1.0"		Present				-	12	NM_032444.2	c.4500T>C	synonymous	0.83				BTB/POZ domain	rs3810812		0.306 (ref)	0.4923	0.1406	0.3734	YES	"3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding"			0.00001	8430.19	"A=0, G=555"		"A=0/0, G=238/317"	1	
chr16:3639827	G/A	G	SNV		SLX4	exonic	1								52.73	p.Ser1271Phe		1997	"G=0.4727, A=0.5273"		Present				-	12	NM_032444.2	c.3812C>T	missense	2.88	0	155	0.999	BTB/POZ domain	rs3810813		0.074 (ref)	0.0545	0.0132	0.0406	YES	"3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding"			0.00001	10084.9	"G=944, A=1053"		"G=466/478, A=538/515"	3	
chr16:3656482	T/T	C	SNV		SLX4	exonic	1								100	p.(=)		1748	"C=0.0, T=1.0"		Present				-	3	NM_032444.2	c.753G>A	synonymous	-3.47				BTB/POZ domain	rs8061528		0.25 (ref)	0.203	0.2501	0.2189	YES	"3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding"			0.00001	26171.6	"C=0, T=1748"		"C=0/0, T=870/878"	4	
chr16:89836323	C/T	C	SNV		FANCA	exonic	1								49.25	p.Gly809Asp		2000	"C=0.5075, T=0.4925"		Present				-	26	NM_000135.2	c.2426G>A	missense	-0.2	0.78	94	0	Fanconi anaemia group A protein	rs7195066		0.384 (ref)	0.3142	0.3414	0.4307	YES	"DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation"			0.00001	9173.51	"C=1015, T=985"		"C=535/480, T=501/484"	2	
chr16:89866043	C/C	T	SNV		FANCA	exonic	1								100	p.Thr266Ala		1991	"T=0.0, C=1.0"		Present				-	9	NM_000135.2	c.796A>G	missense	0.38	1	58	0	Fanconi anaemia group A protein	rs7190823		0.343 (ref)	0.3937	0.2743	0.494	YES	"DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation"			0.00001	30159.3	"T=0, C=1991"		"T=0/0, C=929/1062"	1	
chr17:7579472	G/C	G	SNV		TP53	exonic	1								46.55	p.Pro72Arg		1407	"G=0.5345, C=0.4655"		Present				-	4	NM_000546.5	c.215C>G	missense	1.36	0.6	103	0.083	"P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif"	rs1042522		0.398 (ref)	0.2548	0.4051	0.37	YES	"ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding"	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	non-pathogenic	0.00001	5861.99	"G=752, C=655"		"G=295/457, C=275/380"	6	
chr17:29508775	G/A	G	SNV		NF1	exonic	1								45.02	p.(=)		1999	"G=0.5498, A=0.4502"		Present				+	7	NM_001042492.2	c.702G>A	synonymous	-3.81				GTPase-activator protein for Ras-like GTPase	rs1801052		0.45 (ref)	0.2899	0.3098	0.4256	YES	"MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing"			0.00001	7931.57	"G=1099, A=900"		"G=705/394, A=594/306"	1	
chr17:29553485	G/A	G	SNV		NF1	exonic	1								50.58	p.(=)		1999	"G=0.4942, A=0.5058"		Present				+	18	NM_001042492.2	c.2034G>A	synonymous	-2.42				GTPase-activator protein for Ras-like GTPase	rs2285892		0.471 (ref)	0.2891	0.3352	0.4163	YES	"MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing"			0.00001	9567.8	"G=988, A=1011"		"G=457/531, A=472/539"	1	
chr17:33433487	C/T	C	SNV		"RAD51D,RAD51L3-RFFL"	"exonic_nc, exonic, exonic, exonic, exonic_nc, exonic_nc"	1								52.05	"p.Arg53Gln, p.Arg185Gln, p.Arg165Gln"		1996	"C=0.4795, T=0.5205"		Present				-	6	"NR_037714.1, NM_133629.2, NM_001142571.1, NM_002878.3, NR_037712.1, NR_037711.1"	"c.158G>A, c.554G>A, c.494G>A"	"missense, missense, missense"	-0.16		"43.0, 43.0, 43.0"			rs4796033		0.097 (ref)	0.1427	0.0368	0.1068	YES	"ATP binding,DNA binding,DNA metabolic process,DNA recombination,DNA repair,DNA-dependent ATPase activity,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination"			0.00001	10008.8	"C=957, T=1039"		"C=492/465, T=504/535"	2	
chr17:33445549	G/A	G	SNV		"RAD51D,RAD51L3-RFFL"	"intronic_nc, intronic, intronic, exonic, intronic_nc, intronic_nc"	1								53.18	p.(=)		1999	"G=0.4682, A=0.5318"		Present				-	3	"NR_037714.1, NM_133629.2, NM_001142571.1, NM_002878.3, NR_037712.1, NR_037711.1"	c.234C>T	synonymous	1.21					rs9901455		0.191 (ref)	0.082	0.308	0.1585	YES	"ATP binding,DNA binding,DNA metabolic process,DNA recombination,DNA repair,DNA-dependent ATPase activity,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination"			0.00001	10373.8	"G=936, A=1063"		"G=455/481, A=523/540"	2	
chr17:37619236	C/G	C	SNV		CDK12	exonic	1								49.5	p.(=)		1996	"C=0.505, G=0.495"		Present				+	1	NM_016507.3	c.912C>G	synonymous	0.01				"Protein kinase domain,Protein tyrosine kinase"	rs56403491		0.001 (ref)	0.0043	9.00E-04	0.0032		"ATP binding,RNA polymerase II carboxy-terminal domain kinase activity,RNA splicing,cyclin binding,cyclin-dependent protein kinase activity,mRNA processing,nuclear cyclin-dependent protein kinase holoenzyme complex,nuclear speck,nucleolus,nucleotide binding,nucleus,phosphorylation of RNA polymerase II C-terminal domain,protein autophosphorylation,protein binding,protein kinase activity,regulation of MAP kinase activity"			0.00001	9230.15	"C=1008, G=988"		"C=515/493, G=485/503"	3	
chr17:41215907		C	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B15B18				40080				Present			4.04E-08																						0					
chr17:41215907		C	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B16B18				94				Present			9.48E-11																						0					
chr17:56435080	G/C	G	SNV		RNF43	exonic	1								49.32	p.Pro686Arg		1024	"G=0.5068, C=0.4932"		Present				-	9	NM_017763.4	c.2057C>G	missense	0.7	0	103	0.001	Zinc finger	rs9652855		0.08 (ref)	0.1258	0.1182	0.1233	YES	"endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding"			0.00001	4685.49	"G=519, C=505"		"G=268/251, C=233/272"	5	
chr17:56435885	G/T	G	SNV		RNF43	exonic	1								52.26	p.Leu418Met		1238	"G=0.4774, T=0.5226"		Present				-	9	NM_017763.4	c.1252C>A	missense	2.18	0	15	0.948	Zinc finger	rs2526374		0.398 (ref)	0.3591	0.4024	0.3738	YES	"endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding"			0.00001	6204.53	"G=591, T=647"		"G=258/333, T=313/334"	1	
chr17:56436109	C/T	C	SNV		RNF43	exonic	1								53.35	p.Arg343His		1312	"C=0.4665, T=0.5335"		Present				-	9	NM_017763.4	c.1028G>A	missense	0.89	0.02	29	0.999	Zinc finger	rs34523089		0.076 (ref)	0.1585	0.0362	0.1171	YES	"endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding"			0.00001	6848.55	"C=612, T=700"		"C=297/315, T=352/348"	1	
chr17:56492800	T/C	T	SNV		RNF43	exonic	1								51.2	p.Ile47Val		2000	"T=0.488, C=0.512"		Present				-	2	NM_017763.4	c.139A>G	missense	0.97	0.1	29	0.001	Zinc finger	rs3744093		0.392 (ref)	0.3851	0.2174	0.3283	YES	"endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding"			0.00001	9766.11	"T=976, C=1024"		"T=483/493, C=514/510"	1	
chr19:1220371	G/T	G	SNV		STK11	splicesite_5	1								17.08			281	"G=0.8292, T=0.1708"		Present				+	4	NM_000455.4			1.38				"Protein kinase domain,Protein tyrosine kinase"								"ATP binding,Golgi localization,LRR domain binding,anoikis,autophagy,canonical Wnt receptor signaling pathway,cell cycle,cell cycle arrest,cytoplasm,cytosol,energy reserve metabolic process,establishment of cell polarity,glucose homeostasis,insulin receptor signaling pathway,magnesium ion binding,membrane,mitochondrion,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of epithelial cell proliferation involved in prostate gland development,nucleotide binding,nucleus,p53 binding,positive regulation of axonogenesis,positive regulation of gluconeogenesis,positive regulation of protein phosphorylation,positive regulation of transforming growth factor beta receptor signaling pathway,protein autophosphorylation,protein binding,protein complex,protein heterooligomerization,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of Wnt receptor signaling pathway,regulation of cell growth,regulation of fatty acid biosynthetic process,regulation of fatty acid oxidation,regulation of protein kinase B signaling cascade,response to DNA damage stimulus,response to glucagon stimulus,response to ionizing radiation,response to lipid,signal transduction by p53 class mediator resulting in induction of apoptosis,tissue homeostasis,vasculature development"			0.00001	219.876	"G=233, T=48"		"G=127/106, T=23/25"	2	
chr19:15271771	A/A	G	SNV		NOTCH3	exonic	1								100	p.Ala2223Val		1018	"G=0.0, A=1.0"		Present				-	33	NM_000435.2	c.6668C>T	missense	0.08	0.18	64	0.001	"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1044009		0.368 (ref)	0.1987	0.397	0.2651	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	15405	"G=0, A=1018"		"G=0/0, A=455/563"	1	
chr19:15272001	C/T	C	SNV		NOTCH3	exonic	1								70.45	p.(=)		291	"C=0.2955, T=0.7045"		Present				-	33	NM_000435.2	c.6438G>A	synonymous	-2.58				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1044008		0.023 (ref)	0.033	0.0054	0.0238	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	2331.31	"C=86, T=205"		"C=45/41, T=113/92"	3	
chr19:15278057	G/G	A	SNV		NOTCH3	splicesite_3	1								100			1174	"A=0.0, G=1.0"		Present				-	29	NM_000435.2			0.62				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1548555		0.133 (ref)	0.1034	0.0236	0.0763	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	17822.5	"A=0, G=1174"		"A=0/0, G=535/639"	2	
chr19:15285052	C/C	T	SNV		NOTCH3	exonic	1								100	p.(=)		520	"T=0.0, C=1.0"		Present				-	25	NM_000435.2	c.4563A>G	synonymous	-1.43				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1044006		0.133 (ref)	0.1002	0.0223	0.0739	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	7805.66	"T=0, C=520"		"T=0/0, C=235/285"	1	
chr19:15292437	C/C	T	SNV		NOTCH3	exonic	1								100	p.(=)		324	"T=0.0, C=1.0"		Present				-	17	NM_000435.2	c.2742A>G	synonymous	-4.38				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1043997		0.233 (ref)	0.1299	0.3636	0.2095	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	4842.15	"T=0, C=324"		"T=0/0, C=177/147"	1	
chr19:15295134	G/A	G	SNV		NOTCH3	exonic	1								62.41	p.(=)		721	"G=0.3759, A=0.6241"		Present				-	16	NM_000435.2	c.2538C>T	synonymous	-0.59				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1043996		0.462 (ref)	0.2849	0.2762	0.4336	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	4799.1	"G=271, A=450"		"G=148/123, A=197/253"	1	
chr19:15298099	G/A	G	SNV		NOTCH3	exonic	1								34.1	p.Pro553Ser		1469	"G=0.659, A=0.341"		Present				-	11	NM_000435.2	c.1657C>T	missense	2.22	0	74	1	"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"								"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	3692.03	"G=968, A=501"		"G=520/448, A=251/250"	3	
chr19:15302844	C/C	T	SNV		NOTCH3	exonic	1								100	p.(=)		1220	"T=0.0, C=1.0"		Present				-	4	NM_000435.2	c.606A>G	synonymous	-2.59				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs1043994		0.144 (ref)	0.1224	0.0878	0.1107	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	18466.2	"T=0, C=1220"		"T=0/0, C=563/657"	1	
chr19:15303225	G/A	G	SNV		NOTCH3	exonic	1								41.46	p.(=)		767	"G=0.5854, A=0.4146"		Present				-	3	NM_000435.2	c.303C>T	synonymous	-0.55				"Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein"	rs3815188		0.238 (ref)	0.147	0.2544	0.1834	YES	"Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration"			0.00001	2642.4	"G=449, A=318"		"G=243/206, A=171/147"	2	
chr19:30314666	C/T	C	SNV		CCNE1	exonic	1								59.26	p.(=)		1846	"C=0.4074, T=0.5926"		Present				+	12	NM_001238.2	c.1215C>T	synonymous	-1.18				Cyclin	rs7257694		0.216 (ref)	0.3899	0.111	0.2954	YES	"DNA-dependent DNA replication initiation,G1/S transition of mitotic cell cycle,Wnt receptor signaling pathway,androgen receptor binding,androgen receptor signaling pathway,antral ovarian follicle growth,cell division,cellular response to nutrient,centrosome,cyclin-dependent protein kinase holoenzyme complex,cyclin-dependent protein kinase regulator activity,cytoplasm,cytosol,kinase activity,liver development,mitotic cell cycle,nucleolus,nucleoplasm,nucleus,organ regeneration,positive regulation of cell differentiation,positive regulation of transcription, DNA-dependent,protein binding,protein kinase binding,protein phosphorylation,regulation of cyclin-dependent protein kinase activity,regulation of transcription involved in G1/S phase of mitotic cell cycle,response to corticosterone stimulus,response to cytokine stimulus,response to drug,response to estradiol stimulus,response to ethanol,response to methylmercury,response to organic nitrogen,response to progesterone stimulus,response to purine-containing compound,response to vitamin E,transcription coactivator activity"			0.00001	11357.2	"C=752, T=1094"		"C=423/329, T=609/485"	1	
chr20:36030939	C/C	G	SNV		SRC	exonic	1								100	p.(=)		829	"G=0.0, C=1.0"		Present				+	12	NM_198291.2	c.1218G>C	synonymous	-2.02				"Protein kinase domain,Protein tyrosine kinase,SH2 domain,SH3 domain,Variant SH3 domain"	rs1885257		0.012 (ref)					"ATP binding,Ras protein signal transduction,SH2 domain binding,SH3/SH2 adaptor activity,T cell costimulation,axon guidance,blood coagulation,bone resorption,branching involved in mammary gland duct morphogenesis,caveola,cell adhesion,cell cycle,cell junction assembly,cellular membrane organization,cytoplasm,cytoskeleton,cytosol,ephrin receptor binding,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,forebrain development,heme binding,integrin binding,interspecies interaction between organisms,intracellular protein kinase cascade,ion channel binding,kinase activity,leukocyte migration,mitochondrial inner membrane,mitochondrion,nerve growth factor receptor signaling pathway,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,oogenesis,peptidyl-tyrosine phosphorylation,phosphorylation,plasma membrane,platelet activation,positive regulation of integrin activation,protein binding,protein kinase activity,protein phosphorylation,protein tyrosine kinase activity,receptor binding,regulation of bone resorption,regulation of intracellular estrogen receptor signaling pathway,regulation of vascular permeability,response to interleukin-1,signal complex assembly,signal transduction,uterus development"	"(2E)-N-{4-(3-bromophenyl)aminoquinazolin-6-yl}-4-(dimethylamino)but-2-enamide,1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo3,4-dpyrimidin-4-amine,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-naphthalen-1-ylurea,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-phenylurea,1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo3,4-dpyrimidin-4-amine,1-cyclopentyl-3-(1H-pyrrolo2,3-bpyridin-5-yl)-1H-pyrazolo3,4-dpyrimidin-4-amine,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,3-4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO3,4-DPYRIMIDIN-3-YLPHENOL,4-(4-METHYL-1-PIPERAZINYL)METHYL-N-3-4-(3-PYRIDINYL)-2-PYRIMIDINYLAMINOPHENYL-BENZAMIDE,4-({4-(5-cyclopropyl-1H-pyrazol-3-yl)aminoquinazolin-2-yl}amino)phenylacetonitrile,Citric Acid,DPI59,Dasatinib,ISO24,Malonic acid,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,N6-Benzyl Adenosine-5'-Diphosphate,Oxalic Acid,PAS219,PASBN,Phenylphosphate,Phosphonotyrosine,Purvalanol A,RU78191,RU78262,RU78299,RU78300,RU78783,RU79072,RU79073,RU79256,RU81843,RU82129,RU82197,RU82209,RU83876,RU84687,RU85053,RU85493,RU90395"		0.00001	12571.9	"G=0, C=829"		"G=0/0, C=414/415"	2	
chrX:66766604		G	GENE_EXPRESSION		AR								AR.E1E2				54				Present			5.44E-11																						0					
chrX:66931531		G	GENE_EXPRESSION		AR								AR-AR.A4A8.V12				57				Present			5.75E-11																						0					
chrX:66942826		T	GENE_EXPRESSION		AR								AR-AR.E7E8.V14				110				Present			1.11E-10																						0					
chrX:66942826		T	GENE_EXPRESSION		AR								AR.E7E8				281222				Present			2.84E-07																						0					
chrX:76849215	C/A	C	SNV		ATRX	exonic	1								33.82	p.Val2021Leu		1168	"C=0.6618, A=0.3382"		Present				-	26	NM_000489.4	c.6061G>T	missense	2.28	0.1	32	0.726	"Helicase conserved C-terminal domain,SNF2 family N-terminal domain"								"ATP binding,DNA binding,DNA helicase activity,DNA methylation,DNA recombination,DNA repair,chromatin binding,chromo shadow domain binding,forebrain development,helicase activity,hydrolase activity,metal ion binding,nuclear chromosome,nuclear heterochromatin,nucleotide binding,nucleus,protein binding,regulation of transcription, DNA-dependent,zinc ion binding"			0.00001	2883.55	"C=773, A=395"		"C=356/417, A=201/194"	2	